nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—Serum creatinine increased—Entecavir—hepatitis B	0.0181	0.0222	CcSEcCtD
Aprepitant—Serum creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0177	0.0216	CcSEcCtD
Aprepitant—Glycosuria—Entecavir—hepatitis B	0.0138	0.0168	CcSEcCtD
Aprepitant—Pharyngolaryngeal pain—Telbivudine—hepatitis B	0.0136	0.0166	CcSEcCtD
Aprepitant—Laryngeal pain—Telbivudine—hepatitis B	0.0134	0.0164	CcSEcCtD
Aprepitant—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.0134	0.0164	CcSEcCtD
Aprepitant—Chest discomfort—Telbivudine—hepatitis B	0.0103	0.0127	CcSEcCtD
Aprepitant—Musculoskeletal pain—Telbivudine—hepatitis B	0.00926	0.0113	CcSEcCtD
Aprepitant—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00829	0.0101	CcSEcCtD
Aprepitant—Respiratory tract infection—Lamivudine—hepatitis B	0.00821	0.01	CcSEcCtD
Aprepitant—Blood creatinine increased—Entecavir—hepatitis B	0.00758	0.00927	CcSEcCtD
Aprepitant—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00739	0.00904	CcSEcCtD
Aprepitant—Abdominal pain upper—Entecavir—hepatitis B	0.00739	0.00904	CcSEcCtD
Aprepitant—Renal impairment—Telbivudine—hepatitis B	0.00698	0.00854	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00696	0.00851	CcSEcCtD
Aprepitant—Neutropenia—Entecavir—hepatitis B	0.00654	0.008	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Entecavir—hepatitis B	0.0065	0.00795	CcSEcCtD
Aprepitant—Hyperglycaemia—Entecavir—hepatitis B	0.00631	0.00771	CcSEcCtD
Aprepitant—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00617	0.00755	CcSEcCtD
Aprepitant—Renal failure—Entecavir—hepatitis B	0.00613	0.0075	CcSEcCtD
Aprepitant—Abdominal pain upper—Telbivudine—hepatitis B	0.00607	0.00742	CcSEcCtD
Aprepitant—Cramp muscle—Telbivudine—hepatitis B	0.00598	0.00732	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00598	0.00732	CcSEcCtD
Aprepitant—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00598	0.00731	CcSEcCtD
Aprepitant—Haematuria—Entecavir—hepatitis B	0.00594	0.00727	CcSEcCtD
Aprepitant—Gastritis—Telbivudine—hepatitis B	0.00588	0.00719	CcSEcCtD
Aprepitant—Muscular weakness—Telbivudine—hepatitis B	0.00586	0.00717	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00586	0.00717	CcSEcCtD
Aprepitant—Haematuria—Adefovir Dipivoxil—hepatitis B	0.0058	0.00709	CcSEcCtD
Aprepitant—Abdominal distension—Telbivudine—hepatitis B	0.00578	0.00707	CcSEcCtD
Aprepitant—Oropharyngeal pain—Lamivudine—hepatitis B	0.00567	0.00694	CcSEcCtD
Aprepitant—Abdominal discomfort—Telbivudine—hepatitis B	0.0055	0.00673	CcSEcCtD
Aprepitant—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00542	0.00663	CcSEcCtD
Aprepitant—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00539	0.0066	CcSEcCtD
Aprepitant—Neutropenia—Telbivudine—hepatitis B	0.00537	0.00657	CcSEcCtD
Aprepitant—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00536	0.00656	CcSEcCtD
Aprepitant—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00535	0.00655	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00534	0.00653	CcSEcCtD
Aprepitant—Musculoskeletal pain—Lamivudine—hepatitis B	0.00522	0.00639	CcSEcCtD
Aprepitant—Eructation—Lamivudine—hepatitis B	0.00507	0.0062	CcSEcCtD
Aprepitant—Immune system disorder—Entecavir—hepatitis B	0.00505	0.00618	CcSEcCtD
Aprepitant—Renal failure—Telbivudine—hepatitis B	0.00503	0.00616	CcSEcCtD
Aprepitant—Neuropathy peripheral—Telbivudine—hepatitis B	0.00502	0.00614	CcSEcCtD
Aprepitant—Wheezing—Lamivudine—hepatitis B	0.00501	0.00613	CcSEcCtD
Aprepitant—Alopecia—Entecavir—hepatitis B	0.00494	0.00605	CcSEcCtD
Aprepitant—Mental disorder—Entecavir—hepatitis B	0.0049	0.006	CcSEcCtD
Aprepitant—Malnutrition—Entecavir—hepatitis B	0.00487	0.00596	CcSEcCtD
Aprepitant—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00475	0.00581	CcSEcCtD
Aprepitant—CYP3A5—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00471	0.0294	CbGpPWpGaD
Aprepitant—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00468	0.00573	CcSEcCtD
Aprepitant—Urine output increased—Lamivudine—hepatitis B	0.00466	0.00571	CcSEcCtD
Aprepitant—Back pain—Adefovir Dipivoxil—hepatitis B	0.0046	0.00562	CcSEcCtD
Aprepitant—Hypoaesthesia—Telbivudine—hepatitis B	0.00457	0.00559	CcSEcCtD
Aprepitant—Pharyngitis—Telbivudine—hepatitis B	0.00456	0.00558	CcSEcCtD
Aprepitant—Connective tissue disorder—Telbivudine—hepatitis B	0.00452	0.00553	CcSEcCtD
Aprepitant—TACR3—Peptide GPCRs—CCR5—hepatitis B	0.00442	0.0276	CbGpPWpGaD
Aprepitant—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00439	0.00537	CcSEcCtD
Aprepitant—Polyuria—Lamivudine—hepatitis B	0.00426	0.00522	CcSEcCtD
Aprepitant—Cough—Adefovir Dipivoxil—hepatitis B	0.00415	0.00507	CcSEcCtD
Aprepitant—Mediastinal disorder—Telbivudine—hepatitis B	0.00414	0.00507	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00412	0.00504	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—MIF—hepatitis B	0.00405	0.0253	CbGpPWpGaD
Aprepitant—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00405	0.00495	CcSEcCtD
Aprepitant—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00405	0.00495	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00402	0.00492	CcSEcCtD
Aprepitant—Malnutrition—Telbivudine—hepatitis B	0.004	0.00489	CcSEcCtD
Aprepitant—Anaphylactic shock—Entecavir—hepatitis B	0.00397	0.00486	CcSEcCtD
Aprepitant—Infection—Entecavir—hepatitis B	0.00395	0.00483	CcSEcCtD
Aprepitant—Thirst—Lamivudine—hepatitis B	0.00393	0.00481	CcSEcCtD
Aprepitant—Renal impairment—Lamivudine—hepatitis B	0.00393	0.00481	CcSEcCtD
Aprepitant—Dysgeusia—Telbivudine—hepatitis B	0.00392	0.00479	CcSEcCtD
Aprepitant—Nervous system disorder—Entecavir—hepatitis B	0.0039	0.00477	CcSEcCtD
Aprepitant—Back pain—Telbivudine—hepatitis B	0.00387	0.00473	CcSEcCtD
Aprepitant—Skin disorder—Entecavir—hepatitis B	0.00386	0.00472	CcSEcCtD
Aprepitant—Muscle spasms—Telbivudine—hepatitis B	0.00385	0.00471	CcSEcCtD
Aprepitant—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0038	0.00465	CcSEcCtD
Aprepitant—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.0038	0.00465	CcSEcCtD
Aprepitant—CYP3A7—Xenobiotics—CYP2A6—hepatitis B	0.00379	0.0237	CbGpPWpGaD
Aprepitant—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00377	0.00461	CcSEcCtD
Aprepitant—Ill-defined disorder—Telbivudine—hepatitis B	0.00371	0.00454	CcSEcCtD
Aprepitant—Anorexia—Adefovir Dipivoxil—hepatitis B	0.0037	0.00452	CcSEcCtD
Aprepitant—Malaise—Telbivudine—hepatitis B	0.00361	0.00441	CcSEcCtD
Aprepitant—Insomnia—Entecavir—hepatitis B	0.0036	0.0044	CcSEcCtD
Aprepitant—CYP1A2—Estrogen Receptor Pathway—NR0B2—hepatitis B	0.00357	0.0223	CbGpPWpGaD
Aprepitant—Somnolence—Entecavir—hepatitis B	0.00353	0.00432	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00353	0.00432	CcSEcCtD
Aprepitant—Dyspepsia—Entecavir—hepatitis B	0.0035	0.00428	CcSEcCtD
Aprepitant—Cough—Telbivudine—hepatitis B	0.00349	0.00427	CcSEcCtD
Aprepitant—Dehydration—Lamivudine—hepatitis B	0.00348	0.00426	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Entecavir—hepatitis B	0.00343	0.0042	CcSEcCtD
Aprepitant—Fatigue—Entecavir—hepatitis B	0.00343	0.00419	CcSEcCtD
Aprepitant—Abdominal pain upper—Lamivudine—hepatitis B	0.00342	0.00418	CcSEcCtD
Aprepitant—CYP2C19—CYP2E1 reactions—CYP2A6—hepatitis B	0.00342	0.0213	CbGpPWpGaD
Aprepitant—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00341	0.00418	CcSEcCtD
Aprepitant—Chest pain—Telbivudine—hepatitis B	0.00341	0.00417	CcSEcCtD
Aprepitant—Arthralgia—Telbivudine—hepatitis B	0.00341	0.00417	CcSEcCtD
Aprepitant—Myalgia—Telbivudine—hepatitis B	0.00341	0.00417	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00338	0.00414	CcSEcCtD
Aprepitant—Cramp muscle—Lamivudine—hepatitis B	0.00337	0.00412	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00337	0.00412	CcSEcCtD
Aprepitant—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00337	0.00412	CcSEcCtD
Aprepitant—Discomfort—Telbivudine—hepatitis B	0.00337	0.00412	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00335	0.0041	CcSEcCtD
Aprepitant—Muscular weakness—Lamivudine—hepatitis B	0.0033	0.00404	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.0033	0.00404	CcSEcCtD
Aprepitant—Abdominal distension—Lamivudine—hepatitis B	0.00326	0.00399	CcSEcCtD
Aprepitant—Gastrointestinal pain—Entecavir—hepatitis B	0.00325	0.00398	CcSEcCtD
Aprepitant—Dysphagia—Lamivudine—hepatitis B	0.00324	0.00396	CcSEcCtD
Aprepitant—Nervous system disorder—Telbivudine—hepatitis B	0.0032	0.00392	CcSEcCtD
Aprepitant—Thrombocytopenia—Telbivudine—hepatitis B	0.0032	0.00391	CcSEcCtD
Aprepitant—Skin disorder—Telbivudine—hepatitis B	0.00317	0.00388	CcSEcCtD
Aprepitant—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00317	0.00388	CcSEcCtD
Aprepitant—Sweating increased—Lamivudine—hepatitis B	0.00315	0.00386	CcSEcCtD
Aprepitant—Body temperature increased—Entecavir—hepatitis B	0.00314	0.00384	CcSEcCtD
Aprepitant—Abdominal pain—Entecavir—hepatitis B	0.00314	0.00384	CcSEcCtD
Aprepitant—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.00311	0.0195	CbGpPWpGaD
Aprepitant—Abdominal discomfort—Lamivudine—hepatitis B	0.0031	0.0038	CcSEcCtD
Aprepitant—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00307	0.00375	CcSEcCtD
Aprepitant—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00307	0.00375	CcSEcCtD
Aprepitant—Dysuria—Lamivudine—hepatitis B	0.00303	0.0037	CcSEcCtD
Aprepitant—Neutropenia—Lamivudine—hepatitis B	0.00303	0.0037	CcSEcCtD
Aprepitant—Pollakiuria—Lamivudine—hepatitis B	0.00299	0.00366	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00297	0.00364	CcSEcCtD
Aprepitant—Insomnia—Telbivudine—hepatitis B	0.00295	0.00361	CcSEcCtD
Aprepitant—Paraesthesia—Telbivudine—hepatitis B	0.00293	0.00359	CcSEcCtD
Aprepitant—Hyperglycaemia—Lamivudine—hepatitis B	0.00292	0.00357	CcSEcCtD
Aprepitant—Dyspepsia—Telbivudine—hepatitis B	0.00287	0.00352	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00286	0.0035	CcSEcCtD
Aprepitant—Asthenia—Entecavir—hepatitis B	0.00285	0.00349	CcSEcCtD
Aprepitant—CYP1A2—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00284	0.0177	CbGpPWpGaD
Aprepitant—Renal failure—Lamivudine—hepatitis B	0.00284	0.00347	CcSEcCtD
Aprepitant—Neuropathy peripheral—Lamivudine—hepatitis B	0.00283	0.00346	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00282	0.00345	CcSEcCtD
Aprepitant—Fatigue—Telbivudine—hepatitis B	0.00282	0.00344	CcSEcCtD
Aprepitant—Stomatitis—Lamivudine—hepatitis B	0.00281	0.00344	CcSEcCtD
Aprepitant—Pain—Telbivudine—hepatitis B	0.00279	0.00342	CcSEcCtD
Aprepitant—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00278	0.0034	CcSEcCtD
Aprepitant—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00274	0.00336	CcSEcCtD
Aprepitant—CYP3A5—Xenobiotics—CYP2A6—hepatitis B	0.00274	0.0171	CbGpPWpGaD
Aprepitant—Diarrhoea—Entecavir—hepatitis B	0.00272	0.00333	CcSEcCtD
Aprepitant—Feeling abnormal—Telbivudine—hepatitis B	0.00269	0.00329	CcSEcCtD
Aprepitant—TACR3—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.00268	0.0167	CbGpPWpGaD
Aprepitant—Gastrointestinal pain—Telbivudine—hepatitis B	0.00267	0.00327	CcSEcCtD
Aprepitant—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00265	0.00325	CcSEcCtD
Aprepitant—CYP3A5—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00263	0.0164	CbGpPWpGaD
Aprepitant—Dizziness—Entecavir—hepatitis B	0.00263	0.00322	CcSEcCtD
Aprepitant—CYP2C19—blood plasma—hepatitis B	0.00258	0.115	CbGeAlD
Aprepitant—Body temperature increased—Telbivudine—hepatitis B	0.00258	0.00316	CcSEcCtD
Aprepitant—Abdominal pain—Telbivudine—hepatitis B	0.00258	0.00316	CcSEcCtD
Aprepitant—Hypoaesthesia—Lamivudine—hepatitis B	0.00258	0.00315	CcSEcCtD
Aprepitant—Pharyngitis—Lamivudine—hepatitis B	0.00257	0.00315	CcSEcCtD
Aprepitant—Connective tissue disorder—Lamivudine—hepatitis B	0.00255	0.00311	CcSEcCtD
Aprepitant—Vomiting—Entecavir—hepatitis B	0.00253	0.00309	CcSEcCtD
Aprepitant—Rash—Entecavir—hepatitis B	0.00251	0.00307	CcSEcCtD
Aprepitant—Dermatitis—Entecavir—hepatitis B	0.0025	0.00306	CcSEcCtD
Aprepitant—Headache—Entecavir—hepatitis B	0.00249	0.00305	CcSEcCtD
Aprepitant—TACR1—blood—hepatitis B	0.00248	0.11	CbGeAlD
Aprepitant—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00247	0.00302	CcSEcCtD
Aprepitant—Erythema multiforme—Lamivudine—hepatitis B	0.00245	0.003	CcSEcCtD
Aprepitant—Rash—Adefovir Dipivoxil—hepatitis B	0.00245	0.00299	CcSEcCtD
Aprepitant—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00244	0.00299	CcSEcCtD
Aprepitant—Headache—Adefovir Dipivoxil—hepatitis B	0.00243	0.00297	CcSEcCtD
Aprepitant—Nausea—Entecavir—hepatitis B	0.00236	0.00289	CcSEcCtD
Aprepitant—Asthenia—Telbivudine—hepatitis B	0.00234	0.00287	CcSEcCtD
Aprepitant—Immune system disorder—Lamivudine—hepatitis B	0.00234	0.00286	CcSEcCtD
Aprepitant—Mediastinal disorder—Lamivudine—hepatitis B	0.00233	0.00286	CcSEcCtD
Aprepitant—Chills—Lamivudine—hepatitis B	0.00232	0.00284	CcSEcCtD
Aprepitant—Pruritus—Telbivudine—hepatitis B	0.00231	0.00283	CcSEcCtD
Aprepitant—Nausea—Adefovir Dipivoxil—hepatitis B	0.0023	0.00282	CcSEcCtD
Aprepitant—Alopecia—Lamivudine—hepatitis B	0.00229	0.0028	CcSEcCtD
Aprepitant—Malnutrition—Lamivudine—hepatitis B	0.00225	0.00276	CcSEcCtD
Aprepitant—Erythema—Lamivudine—hepatitis B	0.00225	0.00276	CcSEcCtD
Aprepitant—Diarrhoea—Telbivudine—hepatitis B	0.00223	0.00273	CcSEcCtD
Aprepitant—CYP3A5—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00223	0.0139	CbGpPWpGaD
Aprepitant—Flatulence—Lamivudine—hepatitis B	0.00222	0.00272	CcSEcCtD
Aprepitant—Dysgeusia—Lamivudine—hepatitis B	0.00221	0.0027	CcSEcCtD
Aprepitant—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00219	0.0137	CbGpPWpGaD
Aprepitant—Back pain—Lamivudine—hepatitis B	0.00218	0.00267	CcSEcCtD
Aprepitant—Muscle spasms—Lamivudine—hepatitis B	0.00217	0.00265	CcSEcCtD
Aprepitant—Dizziness—Telbivudine—hepatitis B	0.00216	0.00264	CcSEcCtD
Aprepitant—TACR1—Peptide GPCRs—CCR5—hepatitis B	0.00216	0.0135	CbGpPWpGaD
Aprepitant—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.00212	0.0132	CbGpPWpGaD
Aprepitant—Tremor—Lamivudine—hepatitis B	0.00211	0.00258	CcSEcCtD
Aprepitant—CYP1A2—blood plasma—hepatitis B	0.00211	0.0938	CbGeAlD
Aprepitant—Ill-defined disorder—Lamivudine—hepatitis B	0.00209	0.00256	CcSEcCtD
Aprepitant—Anaemia—Lamivudine—hepatitis B	0.00208	0.00255	CcSEcCtD
Aprepitant—TACR3—Peptide ligand-binding receptors—CCR5—hepatitis B	0.00208	0.013	CbGpPWpGaD
Aprepitant—Vomiting—Telbivudine—hepatitis B	0.00208	0.00254	CcSEcCtD
Aprepitant—Angioedema—Lamivudine—hepatitis B	0.00206	0.00252	CcSEcCtD
Aprepitant—Rash—Telbivudine—hepatitis B	0.00206	0.00252	CcSEcCtD
Aprepitant—Dermatitis—Telbivudine—hepatitis B	0.00206	0.00252	CcSEcCtD
Aprepitant—Headache—Telbivudine—hepatitis B	0.00205	0.0025	CcSEcCtD
Aprepitant—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00204	0.0127	CbGpPWpGaD
Aprepitant—CYP3A5—blood plasma—hepatitis B	0.00204	0.0905	CbGeAlD
Aprepitant—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00204	0.0127	CbGpPWpGaD
Aprepitant—Malaise—Lamivudine—hepatitis B	0.00203	0.00249	CcSEcCtD
Aprepitant—Syncope—Lamivudine—hepatitis B	0.00202	0.00247	CcSEcCtD
Aprepitant—CYP2C9—blood plasma—hepatitis B	0.002	0.089	CbGeAlD
Aprepitant—Loss of consciousness—Lamivudine—hepatitis B	0.00198	0.00242	CcSEcCtD
Aprepitant—CYP1A2—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00197	0.0123	CbGpPWpGaD
Aprepitant—Cough—Lamivudine—hepatitis B	0.00197	0.00241	CcSEcCtD
Aprepitant—Convulsion—Lamivudine—hepatitis B	0.00195	0.00239	CcSEcCtD
Aprepitant—Nausea—Telbivudine—hepatitis B	0.00194	0.00237	CcSEcCtD
Aprepitant—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.00193	0.0121	CbGpPWpGaD
Aprepitant—Chest pain—Lamivudine—hepatitis B	0.00192	0.00235	CcSEcCtD
Aprepitant—Arthralgia—Lamivudine—hepatitis B	0.00192	0.00235	CcSEcCtD
Aprepitant—Myalgia—Lamivudine—hepatitis B	0.00192	0.00235	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—CXCL10—hepatitis B	0.00192	0.012	CbGpPWpGaD
Aprepitant—Anxiety—Lamivudine—hepatitis B	0.00191	0.00234	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00191	0.00233	CcSEcCtD
Aprepitant—Discomfort—Lamivudine—hepatitis B	0.0019	0.00232	CcSEcCtD
Aprepitant—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00188	0.0117	CbGpPWpGaD
Aprepitant—Dry mouth—Lamivudine—hepatitis B	0.00188	0.0023	CcSEcCtD
Aprepitant—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00186	0.0116	CbGpPWpGaD
Aprepitant—Confusional state—Lamivudine—hepatitis B	0.00186	0.00227	CcSEcCtD
Aprepitant—Anaphylactic shock—Lamivudine—hepatitis B	0.00184	0.00225	CcSEcCtD
Aprepitant—Oedema—Lamivudine—hepatitis B	0.00184	0.00225	CcSEcCtD
Aprepitant—Infection—Lamivudine—hepatitis B	0.00183	0.00224	CcSEcCtD
Aprepitant—Shock—Lamivudine—hepatitis B	0.00181	0.00221	CcSEcCtD
Aprepitant—TACR3—G alpha (q) signalling events—F2—hepatitis B	0.00181	0.0113	CbGpPWpGaD
Aprepitant—Nervous system disorder—Lamivudine—hepatitis B	0.0018	0.00221	CcSEcCtD
Aprepitant—Thrombocytopenia—Lamivudine—hepatitis B	0.0018	0.0022	CcSEcCtD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.0018	0.0112	CbGpPWpGaD
Aprepitant—Skin disorder—Lamivudine—hepatitis B	0.00179	0.00219	CcSEcCtD
Aprepitant—TACR3—Peptide ligand-binding receptors—F2—hepatitis B	0.00178	0.0111	CbGpPWpGaD
Aprepitant—Hyperhidrosis—Lamivudine—hepatitis B	0.00178	0.00218	CcSEcCtD
Aprepitant—Anorexia—Lamivudine—hepatitis B	0.00175	0.00215	CcSEcCtD
Aprepitant—Hypotension—Lamivudine—hepatitis B	0.00172	0.0021	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00168	0.00205	CcSEcCtD
Aprepitant—Insomnia—Lamivudine—hepatitis B	0.00166	0.00204	CcSEcCtD
Aprepitant—CYP3A7—liver—hepatitis B	0.00166	0.0736	CbGeAlD
Aprepitant—Paraesthesia—Lamivudine—hepatitis B	0.00165	0.00202	CcSEcCtD
Aprepitant—CYP1A2—Xenobiotics—CYP2A6—hepatitis B	0.00165	0.0103	CbGpPWpGaD
Aprepitant—Dyspnoea—Lamivudine—hepatitis B	0.00164	0.00201	CcSEcCtD
Aprepitant—Somnolence—Lamivudine—hepatitis B	0.00164	0.002	CcSEcCtD
Aprepitant—Dyspepsia—Lamivudine—hepatitis B	0.00162	0.00198	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.00162	0.0101	CbGpPWpGaD
Aprepitant—Decreased appetite—Lamivudine—hepatitis B	0.0016	0.00196	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00159	0.00194	CcSEcCtD
Aprepitant—Fatigue—Lamivudine—hepatitis B	0.00159	0.00194	CcSEcCtD
Aprepitant—CYP1A2—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00159	0.00991	CbGpPWpGaD
Aprepitant—Pain—Lamivudine—hepatitis B	0.00157	0.00193	CcSEcCtD
Aprepitant—Constipation—Lamivudine—hepatitis B	0.00157	0.00193	CcSEcCtD
Aprepitant—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00157	0.00983	CbGpPWpGaD
Aprepitant—CYP3A7—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00155	0.0097	CbGpPWpGaD
Aprepitant—CYP3A4—blood plasma—hepatitis B	0.00153	0.0679	CbGeAlD
Aprepitant—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00152	0.00951	CbGpPWpGaD
Aprepitant—Feeling abnormal—Lamivudine—hepatitis B	0.00152	0.00186	CcSEcCtD
Aprepitant—Gastrointestinal pain—Lamivudine—hepatitis B	0.0015	0.00184	CcSEcCtD
Aprepitant—Urticaria—Lamivudine—hepatitis B	0.00146	0.00179	CcSEcCtD
Aprepitant—Body temperature increased—Lamivudine—hepatitis B	0.00145	0.00178	CcSEcCtD
Aprepitant—Abdominal pain—Lamivudine—hepatitis B	0.00145	0.00178	CcSEcCtD
Aprepitant—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00145	0.00908	CbGpPWpGaD
Aprepitant—CYP3A7-CYP3A51P—liver—hepatitis B	0.00141	0.0626	CbGeAlD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.00139	0.00871	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CXCL10—hepatitis B	0.00137	0.00855	CbGpPWpGaD
Aprepitant—Hypersensitivity—Lamivudine—hepatitis B	0.00136	0.00166	CcSEcCtD
Aprepitant—CYP1A2—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00134	0.00838	CbGpPWpGaD
Aprepitant—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00133	0.00828	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TLR4—hepatitis B	0.00132	0.00828	CbGpPWpGaD
Aprepitant—Asthenia—Lamivudine—hepatitis B	0.00132	0.00162	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—IL10—hepatitis B	0.00131	0.00821	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.00131	0.00818	CbGpPWpGaD
Aprepitant—Pruritus—Lamivudine—hepatitis B	0.0013	0.00159	CcSEcCtD
Aprepitant—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00128	0.00797	CbGpPWpGaD
Aprepitant—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.00127	0.00795	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—NOS2—hepatitis B	0.00126	0.00787	CbGpPWpGaD
Aprepitant—Diarrhoea—Lamivudine—hepatitis B	0.00126	0.00154	CcSEcCtD
Aprepitant—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00122	0.00765	CbGpPWpGaD
Aprepitant—Dizziness—Lamivudine—hepatitis B	0.00122	0.00149	CcSEcCtD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.0012	0.00747	CbGpPWpGaD
Aprepitant—Vomiting—Lamivudine—hepatitis B	0.00117	0.00143	CcSEcCtD
Aprepitant—Rash—Lamivudine—hepatitis B	0.00116	0.00142	CcSEcCtD
Aprepitant—Dermatitis—Lamivudine—hepatitis B	0.00116	0.00142	CcSEcCtD
Aprepitant—Headache—Lamivudine—hepatitis B	0.00115	0.00141	CcSEcCtD
Aprepitant—CYP3A7—Metapathway biotransformation—AKR1B1—hepatitis B	0.00115	0.00718	CbGpPWpGaD
Aprepitant—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00114	0.0071	CbGpPWpGaD
Aprepitant—CYP3A5—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00112	0.00701	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—GGT2—hepatitis B	0.00112	0.00698	CbGpPWpGaD
Aprepitant—Nausea—Lamivudine—hepatitis B	0.00109	0.00134	CcSEcCtD
Aprepitant—TACR3—GPCR ligand binding—CCR5—hepatitis B	0.00106	0.00663	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—RIT2—hepatitis B	0.00105	0.00657	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SAG—hepatitis B	0.00105	0.00657	CbGpPWpGaD
Aprepitant—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00104	0.00647	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CCR5—hepatitis B	0.00102	0.00634	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IFNG—hepatitis B	0.000967	0.00604	CbGpPWpGaD
Aprepitant—CYP2C19—blood—hepatitis B	0.000947	0.0421	CbGeAlD
Aprepitant—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000922	0.00576	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—F2—hepatitis B	0.000911	0.00569	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—F2—hepatitis B	0.000882	0.00551	CbGpPWpGaD
Aprepitant—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000879	0.00549	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000878	0.00549	CbGpPWpGaD
Aprepitant—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000874	0.00546	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—F2—hepatitis B	0.000871	0.00544	CbGpPWpGaD
Aprepitant—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000868	0.00542	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IL2—hepatitis B	0.000859	0.00536	CbGpPWpGaD
Aprepitant—CYP1A2—Phase II conjugation—GGT2—hepatitis B	0.000832	0.0052	CbGpPWpGaD
Aprepitant—CYP3A5—Metapathway biotransformation—AKR1B1—hepatitis B	0.000831	0.00519	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—GGT2—hepatitis B	0.000808	0.00505	CbGpPWpGaD
Aprepitant—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000802	0.00501	CbGpPWpGaD
Aprepitant—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000794	0.00496	CbGpPWpGaD
Aprepitant—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000791	0.00494	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000789	0.00493	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CXCL10—hepatitis B	0.000774	0.00483	CbGpPWpGaD
Aprepitant—CYP1A2—blood—hepatitis B	0.000773	0.0344	CbGeAlD
Aprepitant—CYP3A5—blood—hepatitis B	0.000746	0.0331	CbGeAlD
Aprepitant—CYP2C19—liver—hepatitis B	0.00074	0.0329	CbGeAlD
Aprepitant—CYP2C9—blood—hepatitis B	0.000734	0.0326	CbGeAlD
Aprepitant—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000724	0.00452	CbGpPWpGaD
Aprepitant—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000713	0.00445	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CXCL10—hepatitis B	0.000703	0.00439	CbGpPWpGaD
Aprepitant—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000685	0.00428	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000681	0.00425	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—CYP2A6—hepatitis B	0.000677	0.00423	CbGpPWpGaD
Aprepitant—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000676	0.00422	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TGFB1—hepatitis B	0.00067	0.00418	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CXCL10—hepatitis B	0.000669	0.00418	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000663	0.00414	CbGpPWpGaD
Aprepitant—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00065	0.00406	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000643	0.00402	CbGpPWpGaD
Aprepitant—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000643	0.00401	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.00064	0.004	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TNF—hepatitis B	0.000626	0.00391	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000625	0.0039	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—GGT1—hepatitis B	0.000619	0.00386	CbGpPWpGaD
Aprepitant—CYP1A2—liver—hepatitis B	0.000605	0.0269	CbGeAlD
Aprepitant—TACR3—GPCR downstream signaling—CCR5—hepatitis B	0.0006	0.00375	CbGpPWpGaD
Aprepitant—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000586	0.00366	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000584	0.00365	CbGpPWpGaD
Aprepitant—CYP3A5—liver—hepatitis B	0.000583	0.0259	CbGeAlD
Aprepitant—CYP2C9—liver—hepatitis B	0.000574	0.0255	CbGeAlD
Aprepitant—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.00057	0.00356	CbGpPWpGaD
Aprepitant—CYP3A4—blood—hepatitis B	0.00056	0.0249	CbGeAlD
Aprepitant—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000555	0.00347	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TP53—hepatitis B	0.000552	0.00344	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CCR5—hepatitis B	0.000545	0.0034	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—GGT1—hepatitis B	0.000529	0.0033	CbGpPWpGaD
Aprepitant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000529	0.0033	CbGpPWpGaD
Aprepitant—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000522	0.00326	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CCR5—hepatitis B	0.000519	0.00324	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—F2—hepatitis B	0.000515	0.00322	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SAG—hepatitis B	0.000514	0.00321	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RIT2—hepatitis B	0.000514	0.00321	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IL6—hepatitis B	0.000505	0.00315	CbGpPWpGaD
Aprepitant—CYP1A2—Metapathway biotransformation—AKR1B1—hepatitis B	0.000501	0.00313	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—TNF—hepatitis B	0.0005	0.00313	CbGpPWpGaD
Aprepitant—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000496	0.0031	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—CYP2A6—hepatitis B	0.00049	0.00306	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—GGT2—hepatitis B	0.000487	0.00304	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—F2—hepatitis B	0.000468	0.00292	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—F2—hepatitis B	0.000445	0.00278	CbGpPWpGaD
Aprepitant—CYP3A4—liver—hepatitis B	0.000438	0.0194	CbGeAlD
Aprepitant—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000429	0.00268	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CXCL10—hepatitis B	0.000415	0.00259	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000404	0.00252	CbGpPWpGaD
Aprepitant—CYP1A2—Phase II conjugation—GGT1—hepatitis B	0.000394	0.00246	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000387	0.00241	CbGpPWpGaD
Aprepitant—CYP1A2—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000386	0.00241	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—GGT1—hepatitis B	0.000382	0.00239	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000379	0.00236	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CXCL10—hepatitis B	0.000378	0.00236	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000376	0.00235	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—IL2—hepatitis B	0.000347	0.00217	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000345	0.00216	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CXCL10—hepatitis B	0.000343	0.00214	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCR5—hepatitis B	0.000322	0.00201	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000321	0.00201	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—IL2—hepatitis B	0.000315	0.00197	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.000312	0.00195	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000296	0.00185	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	0.000295	0.00184	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CCR5—hepatitis B	0.000293	0.00183	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000285	0.00178	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—F2—hepatitis B	0.000276	0.00173	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000269	0.00168	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000269	0.00168	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000267	0.00167	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CCR5—hepatitis B	0.000266	0.00166	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—F2—hepatitis B	0.000251	0.00157	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00025	0.00156	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—GGT1—hepatitis B	0.00023	0.00144	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—F2—hepatitis B	0.000228	0.00143	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000228	0.00143	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000228	0.00142	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000223	0.00139	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000208	0.0013	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000208	0.0013	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCL10—hepatitis B	0.000203	0.00127	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKR1B1—hepatitis B	0.000199	0.00125	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000195	0.00122	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GGT2—hepatitis B	0.000191	0.00119	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL2—hepatitis B	0.000186	0.00116	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—IL6—hepatitis B	0.000185	0.00116	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CTNNB1—hepatitis B	0.00018	0.00112	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000178	0.00111	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CDKN1A—hepatitis B	0.000175	0.0011	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PTEN—hepatitis B	0.000175	0.00109	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NFKB1—hepatitis B	0.000174	0.00109	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—IL2—hepatitis B	0.000169	0.00106	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCR5—hepatitis B	0.000157	0.000982	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL2—hepatitis B	0.000154	0.000961	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TGFB1—hepatitis B	0.000145	0.000906	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKR1B1—hepatitis B	0.000144	0.0009	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GGT2—hepatitis B	0.000138	0.000863	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—F2—hepatitis B	0.000135	0.000843	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—hepatitis B	0.000119	0.000746	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP2A6—hepatitis B	0.000116	0.000724	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000113	0.000709	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKR1B1—hepatitis B	0.000111	0.000696	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6—hepatitis B	0.000109	0.000683	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GGT2—hepatitis B	0.000107	0.000667	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GOT2—hepatitis B	0.000105	0.000654	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000103	0.000646	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKR1B1—hepatitis B	0.000102	0.000635	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GGT2—hepatitis B	9.74e-05	0.000609	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL2—hepatitis B	9.09e-05	0.000567	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GGT1—hepatitis B	9.04e-05	0.000565	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GOT1—hepatitis B	9.04e-05	0.000565	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6—hepatitis B	9.04e-05	0.000565	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	8.84e-05	0.000552	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CTNNB1—hepatitis B	8.77e-05	0.000548	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKR1B1—hepatitis B	8.68e-05	0.000542	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDKN1A—hepatitis B	8.57e-05	0.000535	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTEN—hepatitis B	8.55e-05	0.000534	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NFKB1—hepatitis B	8.51e-05	0.000531	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP2A6—hepatitis B	8.37e-05	0.000523	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GGT2—hepatitis B	8.33e-05	0.00052	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GOT2—hepatitis B	7.57e-05	0.000473	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TGFB1—hepatitis B	7.09e-05	0.000443	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKR1B1—hepatitis B	6.7e-05	0.000419	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GOT1—hepatitis B	6.54e-05	0.000408	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GGT1—hepatitis B	6.54e-05	0.000408	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP2A6—hepatitis B	6.47e-05	0.000404	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GGT2—hepatitis B	6.43e-05	0.000401	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	6.04e-05	0.000377	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP2A6—hepatitis B	5.9e-05	0.000369	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GOT2—hepatitis B	5.85e-05	0.000366	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—hepatitis B	5.83e-05	0.000364	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.5e-05	0.000344	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—hepatitis B	5.34e-05	0.000334	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GOT2—hepatitis B	5.34e-05	0.000333	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GGT1—hepatitis B	5.05e-05	0.000316	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GOT1—hepatitis B	5.05e-05	0.000316	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP2A6—hepatitis B	5.04e-05	0.000315	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—hepatitis B	4.81e-05	0.0003	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.7e-05	0.000294	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GOT1—hepatitis B	4.61e-05	0.000288	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GGT1—hepatitis B	4.61e-05	0.000288	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.61e-05	0.000288	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GOT2—hepatitis B	4.56e-05	0.000285	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.2e-05	0.000262	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GGT1—hepatitis B	3.94e-05	0.000246	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GOT1—hepatitis B	3.94e-05	0.000246	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP2A6—hepatitis B	3.89e-05	0.000243	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTEN—hepatitis B	3.67e-05	0.000229	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.59e-05	0.000224	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GOT2—hepatitis B	3.52e-05	0.00022	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—hepatitis B	3.48e-05	0.000217	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GGT1—hepatitis B	3.04e-05	0.00019	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GOT1—hepatitis B	3.04e-05	0.00019	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—hepatitis B	2.69e-05	0.000168	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTEN—hepatitis B	2.65e-05	0.000166	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—hepatitis B	2.45e-05	0.000153	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—hepatitis B	2.09e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTEN—hepatitis B	2.05e-05	0.000128	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTEN—hepatitis B	1.87e-05	0.000117	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—hepatitis B	1.62e-05	0.000101	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTEN—hepatitis B	1.6e-05	9.98e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTEN—hepatitis B	1.23e-05	7.7e-05	CbGpPWpGaD
